HOME CANCER GLOSSARY  CANCER PHOTOS  NEW CANCER BOOKS  LINKING  ADVERTISE

   
 

Free Financial Help for Cancer Patients
Gov't regulated program

Breast Cancer "Switch" Found

Cancer Pictures

Best Natl Cancer Ctrs

Cancer Centers
by State


Cancer Societies

Newest Treatments
by cancer type

MyCancerNews.com

Cancer Newsletters

Medical Journals

Cancer Calculator

Nat'l Cancer Inst.

MedLine Cancer

Chemotherapy

Other helpful links

Additional Help
for Cancer Patients

More Cancer Photos

Diabetes Current Topics in Diabetes

Insulin Pen May Improve Diabetes Outcomes


Medically Reviewed On: October 31, 2006

(HealthCentersOnline) - Using an insulin pen instead of syringe injections may improve compliance and reduce diabetic emergencies, new research suggests.

All people with type 1 diabetes and some people with type 2 and other forms of diabetes must take supplements of insulin, a hormone needed to process glucose (blood sugar) for energy. The most common method of insulin administration is injections using needle-tipped syringes and vials of insulin.

Another injection option is insulin pens, which have short needles and prefilled cartridges or chambers in a single device. Insulin pens are generally less uncomfortable and easier to use but more expensive short-term than syringe injections. They have been more popular in some countries than in the United States.

Scientists with a U.S. corporate research firm and a pharmaceutical company conducted what they described as the first study to compare medical and economic outcomes in patients with type 2 diabetes who switched from syringe injections to insulin pens. They reviewed a healthcare claims database covering more than 40 million people to identify 1,156 adult patients fitting that description.

Their 18-month analysis of these patients who converted to insulin pens indicated that the proportion who complied with their physician-prescribed treatment plan rose from 36 percent to 55 percent. Also, episodes of low glucose, known as hypoglycemia, declined, including a decrease by up to two-thirds in patients who followed their treatment plan at least 80 percent of the time.

Emergency hospital visits due to hypoglycemia declined, with an annual savings of $788 a patient, and total annual savings in treatment costs were $1,590 a patient.

The researchers concluded that switching from insulin syringe injections to insulin pens could improve patient compliance, reduce hypoglycemia and yield long-term savings.

The study was published this month in Clinical Therapeutics.

Copyright 2000-2006 HealthCentersOnline Inc.

 

Alternative Therapies

Melanoma Skin Cancer

Complementary and Alternative Cancer
Care Guidelines

Cancer Treatment Research Library

Dangerous Doctors
...is yours safe?

Cancer Archives

 

 

MEMBERSHIPS:     

About us
Privacy policy
Conditions of use

 


Nat'l Cervical
Cancer Coalition

logo nbtf
National Brain
Tumor
Foundation


Nat'l Ovarian
Cancer Coalition


Breast Cancer
Research

MCN
My
Cancer News

 

Special
Thanks
 TECH SUPPORT

Codebrain
Codebelly


NOTICE:  No information on this CANCER research site is provided, intended or implied to substitute for trained, professional medical advice, CANCER diagnosis or CANCER treatmentAs a condition of use of this cancer website, all visitors agree to seek trained medical advice before using any cancer treatment or cancer information found on this website and agree discuss these with their physicians prior to use and to hold RobertsReview and all entities affiliated with, contributing to, and/or operating this cancer research website harmless in regard to all information provided herein and/or from any decisions that may flow from use of this information.  RobertsReview in no way recommends, endorses or verifies the accuracy or claims of any of the cancer information provided herein by "third parties" regardless of their affiliation.

©1997-2006 RobertsReview, Wickford, RI USA. No information contained on this website may be reproduced in any form in any media.  Single copies may be reprinted for non-commercial use.